Skip to main content

Nextel Medical Corp.

Data quality: 100%
MAJI
OTC Utilities Communications
$0.03
▼ $0.00 (-11.11%)
Mkt Cap: 1.31 M
Price
$0.03
Mkt Cap
1.31 M
Day Range
$0.03 — $0.04
52-Week Range
$0.02 — $0.32
Volume
84,862
Open $0.04
50D / 200D Avg
$0.04
20.99% below
50D / 200D Avg
$0.08
62.26% below

Quick Summary

Key Takeaways

Negative free cash flow of -114,752.0

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio0.00
Interest Coverage-537.31

Valuation

PE (TTM)
-2.53
Below sector avg (3.70)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Utilities sector median (448 peers)
Metric Stock Sector Median
P/E -2.5 3.7
P/B 1.6
ROE % 7.9
Net Margin % 6.8
Rev Growth 5Y % 4.2
D/E 1.0

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0.0 Net Income (TTM) -518,295.0
ROE N/A ROA -103659.00%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -114,752.0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.00
Interest Coverage -537.31 Asset Turnover 0.00
Working Capital -463,253 Tangible Book Value -463,253
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2.53 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -8.75%
Market Cap 1.31 M Enterprise Value 1.31 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share 0.00
FCF / Share 0.00 OCF / Share 0.00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 22.14%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2020 FY2019 FY2012
Revenue 0.0 0.0 0.0
Net Income -435,950.0 -125,164.0 -6.18 M
EPS (Diluted)
Gross Profit
Operating Income -467,862.0 -125,164.0 -6.09 M
EBITDA
R&D Expenses
SG&A Expenses
D&A
Interest Expense 469.0 89,414.0
Income Tax 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2020 FY2019 FY2012
Total Assets 58,265.0 0.0 5,865.0
Total Liabilities 444,776.0 214,286.0 280,311.0
Shareholders' Equity -386,511.0 -214,286.0 -274,446.0
Total Debt
Cash & Equivalents 0.0 0.0 5,865.0
Current Assets 58,265.0 0.0 5,865.0
Current Liabilities 444,776.0 214,286.0 280,311.0